Clearline Capital’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.08M Buy
+31,152
New +$3.76M 0.14% 89

Other funds holding ABVX

Clearline Capital's ABVX Position: Q3 2026 in Review

Clearline Capital opened a new position in Abivax (ABVX) in Q3 2026: 31,152 shares worth $3.08M. The stake represents 0.14% of the portfolio and ranks #89 among its holdings.

319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Clearline Capital held 31,152 shares of Abivax worth $3.08M as of Q3 2026.
  • Abivax was a new Clearline Capital position in Q3 2026.
  • Abivax made up 0.14% of Clearline Capital's portfolio in Q3 2026, its #89 holding.
  • 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Clearline Capital's 13F filing for Q3 2026, filed 16 Nov 2026.